Attached files
file | filename |
---|---|
10-K - FORM 10-K - Protalix BioTherapeutics, Inc. | y03091e10vk.htm |
EX-31.2 - EX-31.2 - Protalix BioTherapeutics, Inc. | y03091exv31w2.htm |
EX-21.1 - EX-21.1 - Protalix BioTherapeutics, Inc. | y03091exv21w1.htm |
EX-31.1 - EX-31.1 - Protalix BioTherapeutics, Inc. | y03091exv31w1.htm |
EX-10.16 - EX-10.16 - Protalix BioTherapeutics, Inc. | y03091exv10w16.htm |
EX-32.1 - EX-32.1 - Protalix BioTherapeutics, Inc. | y03091exv32w1.htm |
EX-32.2 - EX-32.2 - Protalix BioTherapeutics, Inc. | y03091exv32w2.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statement on Form S-8
(No. 333-148983) of Protalix BioTherapeutics, Inc. of our report
dated February 25, 2010, relating
to the consolidated financial statements and the effectiveness of internal control over financial
reporting, which appears in this Form 10-K.
/s/ Kesselman & Kesselman
Tel Aviv, Israel
February 25, 2010
February 25, 2010